Skip to main content

Table 3 Association between KLK15 Single Nucleotide Polymorphisms and ovarian cancer survival in Australian dataset

From: A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival

KLK15 n n censored Adjusted* HR (95% CI) p value (trend)
rs2659058     
TT 123 74 1.0  
CT 138 88 1.13 (0.82-1.55) 0.75
CC 50 26 1.20 (0.75-1.91)  
rs3212810     
CC 207 122 1.0  
TC 87 51 1.01 (0.72-1.41) 0.29
TT 18 14 1.46 (0.82-2.62)  
rs3745522     
GG 187 106 1.0  
GT 81 48 0.97 (0.68-1.39) 0.15
TT 18 13 1.73 (0.93-3.24)  
rs266851     
CC 222 128 1.0  
CT 89 55 1.43 (1.02-2.00)  
TT 7 5 1.26 (0.49-3.24) 0.01
CT/TT 96 60 1.42 (1.02-1.96)  
rs2659055     
TT 84 52 1.0 0.23
TC 144 87 0.86 (0.60-1.23)  
CC 67 36 0.74 (0.47-1.17)  
rs190552     
TT 178 109 1.0 0.79
CT 114 65 1.04 (0.76-1.42)  
CC 19 13 1.21 (0.67-2.17)  
rs2739442     
GG 92 55 1.0 0.99
GA 133 76 1.09 (0.75-1.58)  
AA 89 54 1.08 (0.73-1.62)  
rs2659053     
GG 129 79 1.0 0.2
GA 118 73 0.93 (0.66-1.29)  
AA 63 34 0.95 (0.63-1.44)  
rs2569746     
AA 111 65 1.0 0.43
TA 119 74 0.90 (0.64-1.27)  
TT 57 36 1.12 (0.74-1.69)  
  1. *Adjusted for age, FIGO stage, histological subtype, and grade.